Active · per the CBE, 28 September 2026

ENT

BE0873263185

Rechtspersoon Private limited company 1 establishment

ENT is a specialist medical practice in Anderlecht. Private Limited, started on 18 April 2005, 1 establishment.

Krokussenlaan 11, 1070 Anderlecht

Behind the company: STEPHANE RESIMONT.

Active for

21 year, 5 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Two loss years in a row NBB

    Negative result in 2023 and 2024.

  • Tight liquidity NBB

    Cash and receivables cover 12 % of short-term debt in 2024; threshold 65 %.

  • Not on Peppol Peppol

    Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2024

ENT from Anderlecht, company number BE0873263185, closed financial year 2024 with a result of € -29,999 after tax. For that financial year ENT recorded revenue of € 221,428 and equity of € 72,979. Compared with financial year 2023, the result moved from € -48,180 to € -29,999. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 12, 2025.

What it is worth Healthy

€ 72,979

▼ 29% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -29,999

▲ 38 % less loss than in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 9,273

▲ 192% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 52,979.

People and assets in 2024

Wage cost

€ 108,619

▲ 3% vs 2023

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 6,088

▼ 3% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 3 years to go

€ 144,285

▼ 36% vs 2023

€ 48,372 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 30,784

▲ 28% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 11,614

▼ 20% vs 2023

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2021202220232024Change 2023 → 2024
Revenue € 200,153 € 253,713 € 237,028 € 221,428 ▼ 7%
Gross margin € 41,433 € 124,047 € 100,257 € 102,260 ▲ 2%
Profit after taxes € -89,954 € -21,378 € -48,180 € -29,999 ▲ € 18,181
Equity € 172,536 € 151,158 € 102,978 € 72,979 ▼ 29%
Total debts € 725,378 € 744,082 € 739,678 € 776,152 ▲ 5%
Cash € 540 € 24,063 € 3,179 € 9,273 ▲ 192%
Land & buildings € 1,298 € 626 € 312 € 8 ▼ 97%
Retained profit € 152,536 € 131,158 € 82,978 € 52,979 ▼ 36%
Bank debt € 340,176 € 286,792 € 227,203 € 144,285 ▼ 36%
Balance sheet total € 897,914 € 895,239 € 842,656 € 849,131 ▲ 1%
Employees (FTE) 1.3 - - -

Key figures of ENT, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to ENT?

What happened at ENT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2024: loss of € 29,999. filed late Source: NBB ↗
  • New establishment in Anderlecht. KBO
  • Start of the company according to the CBE. KBO

In short

From € 89,954 loss in 2021 to € 29,999 loss in 2024.

Paid € 2,193 in corporate taxes since 2021.

On average € 31,900 of value added per employee in 2021.

Management

STEPHANE RESIMONT

Behind ENT is STEPHANE RESIMONT. STEPHANE RESIMONT is also behind DAST INVEST and ResiResearch.

See the full network in the app

Directors

According to the 2024 annual accounts

STEPHANE RESIMONT

Director

Also active at: DAST INVEST, ResiResearch

Establishments

Establishment units

Physical locations of this company

Registered office

Krokussenlaan 11

1070 Anderlecht

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0873.263.185
VAT number
BE 0873.263.185
Registered office
Krokussenlaan 11, 1070 Anderlecht
Names & denominations
ENT
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
18 April 2005
Peppol
Not registered
Activities · NACE

Activiteiten van medisch specialisten

Frequently asked questions

What does ENT do?
ENT is a specialist medical practice in Anderlecht. Private Limited, started on 18 April 2005, 1 establishment.
What is the address of ENT?
The registered office of ENT is located at Krokussenlaan 11, 1070 Anderlecht.
Is ENT still active?
Yes. According to the CBE (28 September 2026) ENT is active, legal situation “Normale toestand”, started on 18 April 2005.
Is ENT registered on Peppol?
No, ENT is currently not registered on the Peppol network.
What is the enterprise number of ENT?
The enterprise number of ENT is BE0873263185.
When was ENT founded?
ENT was founded on 18 April 2005.